Diversified API manufacturing industry points to expansion into new capabilities
To meet the needs of generic finished dose and innovative biopharma markets, API producers are expanding their development and manufacturing capabilities. Companies are looking to secure specialized technologies, grow their market share and enter into new markets, further fragmenting the API production landscape. However, the strategies for sustainably creating value from these growth drivers vary across companies, depending largely on level of firm maturity, and often involve decisions of diversification versus specialization.
This report provides data-driven insights on the API manufacturing landscape, manufacturers’ capabilities and experience, and the potential for growth in new products and technologies.
Fill out the form at the right to get your copy now!